Description of Parkinson's disease as a clinical syndrome
- PMID: 12846969
- DOI: 10.1111/j.1749-6632.2003.tb07458.x
Description of Parkinson's disease as a clinical syndrome
Abstract
Parkinsonism is a clinical syndrome comprising combinations of motor problems-namely, bradykinesia, resting tremor, rigidity, flexed posture, "freezing," and loss of postural reflexes. Parkinson's disease (PD) is the major cause of parkinsonism. PD is a slowly progressive parkinsonian syndrome that begins insidiously and usually affects one side of the body before spreading to involve the other side. Pathology shows loss of neuromelanin-containing monoamine neurons, particularly dopamine (DA) neurons in the substantia nigra pars compacta. A pathologic hallmark is the presence of cytoplasmic eosinophilic inclusions (Lewy bodies) in monoamine neurons. The loss of DA content in the nigrostriatal neurons accounts for many of the motor symptoms, which can be ameliorated by DA replacement therapy-that is, levodopa. Most cases are sporadic, of unknown etiology; but rare cases of monogenic mutations (10 genes at present count) show that there are multiple causes for the neuronal degeneration. The pathogenesis of PD remains unknown. Clinical fluctuations and dyskinesias are frequent complications of levodopa therapy; these, as well as some motor features of PD, improve by resetting the abnormal brain physiology towards normal by surgical therapy. Nonmotor symptoms (depression, lack of motivation, passivity, and dementia) are common. As the disease progresses, even motor symptoms become intractable to therapy. No proven means of slowing progression have yet been found.
Similar articles
-
Chapter 33: the history of movement disorders.Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7. Handb Clin Neurol. 2010. PMID: 19892136 Review.
-
Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday.Mov Disord. 2007 Sep;22 Suppl 17:S327-34. doi: 10.1002/mds.21684. Mov Disord. 2007. PMID: 18175393
-
[A 78-year-old man with young onset parkinsonism and sudden death].No To Shinkei. 1996 May;48(5):487-95. No To Shinkei. 1996. PMID: 8672309 Japanese.
-
Parkinson's disease. Diagnosis and the initiation of therapy.Minerva Med. 2005 Jun;96(3):145-54. Minerva Med. 2005. PMID: 16175158 Review.
-
The diagnosis of manganese-induced parkinsonism.Neurotoxicology. 2006 May;27(3):340-6. doi: 10.1016/j.neuro.2005.10.006. Epub 2005 Dec 1. Neurotoxicology. 2006. PMID: 16325915 Review.
Cited by
-
Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.J Speech Lang Hear Res. 2015 Aug;58(4):1134-44. doi: 10.1044/2015_JSLHR-S-14-0243. J Speech Lang Hear Res. 2015. PMID: 26102242 Free PMC article.
-
Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):469-81. doi: 10.2174/187152712800792866. CNS Neurol Disord Drug Targets. 2012. PMID: 22583432 Free PMC article. Review.
-
Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases.Stem Cells Int. 2015;2015:382530. doi: 10.1155/2015/382530. Epub 2015 Jul 9. Stem Cells Int. 2015. PMID: 26240571 Free PMC article. Review.
-
Neuronal vulnerability, pathogenesis, and Parkinson's disease.Mov Disord. 2013 Jan;28(1):41-50. doi: 10.1002/mds.25095. Epub 2012 Jul 12. Mov Disord. 2013. PMID: 22791686 Free PMC article. Review.
-
The Role of the Thioredoxin System in Brain Diseases.Antioxidants (Basel). 2022 Oct 31;11(11):2161. doi: 10.3390/antiox11112161. Antioxidants (Basel). 2022. PMID: 36358532 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
